(March 24, 2010, Jade Valley, Quezon City). Darvys Pharma and PT Novell Laboratories joined forces to formally introduce an exciting product , the oral replacement enzyme ESSENVIDA® (ubiquinone). Ubiquinone is regarded as one of the two most important essential nutrients vital for physiological rejuvenation. The main feature of the event was an intriguing lecture entitled “Statin-Induced Essential Nutrient Depletion: How Critical an Issue?” and “The Role of Ubiquinone” with Dr. Roberto Raymundo, a respected consultant cardiologist, as lecturer.

The lecture’s proposition about statin drugs and their side action depleting the natural-occurring essential enzyme ubiquinone, which is responsible for up to 95% of the body’s energy requirements whetted the interest of the audience as this information was being presented to most of them for the very first time.

The discussion became became interesting and exciting as expert panellists Dr. Amado San Luis (neurology), Dr. Bonifacio Rafanan (Physiatry), Jr and Dr.Vic Caguioa (Cardiology) shared their knowledge and expertise on the subject.